<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05110352</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A02789-30</org_study_id>
    <nct_id>NCT05110352</nct_id>
  </id_info>
  <brief_title>Prevalence of Pharyngolaryngeal Reflux in Patients Treated for Obstructive Sleep Apnea Syndrome</brief_title>
  <acronym>RESTECH</acronym>
  <official_title>Pilot Epidemiological Study to Determine the Prevalence of Pharyngolaryngeal Reflux in Patients Treated for Obstructive Sleep Apnea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elsan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Elsan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to find, using validated and efficient tools, a laryngopharyngeal&#xD;
      reflux in patients receiving polysomnography for suspected obstructive sleep apnea syndrome.&#xD;
&#xD;
      It is proposed to carry out simultaneously, at the Sleep Center of the Polyclinique of&#xD;
      Poitiers (CSPP), a polysomnography, a 24-hour Restech pharyngeal pH-metry (day and night), a&#xD;
      Peptest (in the evening and in the morning of the polysomnography), with the RSS-12&#xD;
      questionnaire and the RSA score.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2021</start_date>
  <completion_date type="Anticipated">January 10, 2022</completion_date>
  <primary_completion_date type="Actual">July 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with Obstructive Sleep Apnea Syndrome diagnosed with pharyngolaryngeal reflux.</measure>
    <time_frame>3 months</time_frame>
    <description>the diagnosis of OSA is posed by the PSG as soon as the AHI is ≥ 15 / h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RSS-12 score</measure>
    <time_frame>3 months</time_frame>
    <description>Positive (&gt;11)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>RSA score</measure>
    <time_frame>3 months</time_frame>
    <description>Positive if &gt; 14</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peptest</measure>
    <time_frame>3 months</time_frame>
    <description>Positive if &gt; 75 ng / mL</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Reflux, Laryngopharyngeal</condition>
  <arm_group>
    <arm_group_label>Obstructive Sleep Apnea Syndrome patients with polysomnography planned</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Apnea-Hypopnea Index (AHI) &gt; 15</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Polysomnography</intervention_name>
    <description>A polysmnography is planned for every patients in order to evaluate the Apnea-Hypopnea Index (AHI).</description>
    <arm_group_label>Obstructive Sleep Apnea Syndrome patients with polysomnography planned</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pharyngeal ph-metry Restech</intervention_name>
    <description>Pharyngeal ph-metry Restech over 24 hours (night and day)</description>
    <arm_group_label>Obstructive Sleep Apnea Syndrome patients with polysomnography planned</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peptest</intervention_name>
    <description>Saliva sample to look for an association between pharyngolaryngeal reflux and obstructive sleep apnea syndrome</description>
    <arm_group_label>Obstructive Sleep Apnea Syndrome patients with polysomnography planned</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire RSS-12</intervention_name>
    <description>Questionnaire with 12 items about quality of life. Score between 0 and 5.</description>
    <arm_group_label>Obstructive Sleep Apnea Syndrome patients with polysomnography planned</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Reflux Sign Assessment</intervention_name>
    <description>RSA score about anatomy and morphology of the mouth</description>
    <arm_group_label>Obstructive Sleep Apnea Syndrome patients with polysomnography planned</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults (&gt; 18 ans)&#xD;
&#xD;
          -  Polysomnography planned for OSA assessment&#xD;
&#xD;
          -  RPL known or not, suspected or not&#xD;
&#xD;
          -  Affiliation to a social security scheme or beneficiary of such a scheme&#xD;
&#xD;
          -  Patient having signed the free and informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minors&#xD;
&#xD;
          -  Smoking, alcoholism, chronic or serious disabling pathology&#xD;
&#xD;
          -  Medical history of upper aerodigestive tract cancer, radiotherapy&#xD;
&#xD;
          -  Recent infection of upper aerodigestive tract, chronic rhinosinusitis&#xD;
&#xD;
          -  Permanent nasal obstruction&#xD;
&#xD;
          -  Active allergy&#xD;
&#xD;
          -  Non-obstructive SAS (central)&#xD;
&#xD;
          -  Patient under anti-secretory treatment (IPP) during the 8 days preceding the Restech&#xD;
             associated with the PSG&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
&#xD;
          -  Protected patients: Adults under guardianship, guardianship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient&#xD;
&#xD;
          -  Hospitalized without consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre du Sommeil de la Polyclinique de Poitiers</name>
      <address>
        <city>Potiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François BOBIN</last_name>
      <phone>05 49 61 70 09</phone>
      <email>Dr_Bobin@polycliniquepoitiers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 21, 2021</study_first_submitted>
  <study_first_submitted_qc>October 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Laryngopharyngeal Reflux</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

